- Home
- CREG vs ENSC Comparison
CREG vs ENSC Comparison
Compare CREG & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREG
- ENSC
- Stock Information
- Founded
- CREG N/A
- ENSC 2003
- Country
- CREG China
- ENSC United States
- Employees
- CREG N/A
- ENSC N/A
- Industry
- CREG Power Generation
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- CREG Utilities
- ENSC Health Care
- Exchange
- CREG Nasdaq
- ENSC Nasdaq
- Market Cap
- CREG 4.8M
- ENSC 5.2M
- IPO Year
- CREG N/A
- ENSC N/A
- Fundamental
- Price
- CREG $1.40
- ENSC $2.15
- Analyst Decision
- CREG
- ENSC
- Analyst Count
- CREG 0
- ENSC 0
- Target Price
- CREG N/A
- ENSC N/A
- AVG Volume (30 Days)
- CREG 780.1K
- ENSC 866.8K
- Earning Date
- CREG 08-13-2025
- ENSC 08-13-2025
- Dividend Yield
- CREG N/A
- ENSC N/A
- EPS Growth
- CREG N/A
- ENSC N/A
- EPS
- CREG N/A
- ENSC N/A
- Revenue
- CREG $20,625.00
- ENSC $6,224,081.00
- Revenue This Year
- CREG N/A
- ENSC N/A
- Revenue Next Year
- CREG N/A
- ENSC $1,381.48
- P/E Ratio
- CREG N/A
- ENSC N/A
- Revenue Growth
- CREG N/A
- ENSC 256.35
- 52 Week Low
- CREG $1.20
- ENSC $1.62
- 52 Week High
- CREG $14.70
- ENSC $14.67
- Technical
- Relative Strength Index (RSI)
- CREG 26.49
- ENSC 48.04
- Support Level
- CREG $2.20
- ENSC $1.95
- Resistance Level
- CREG $2.23
- ENSC $2.37
- Average True Range (ATR)
- CREG 0.22
- ENSC 0.16
- MACD
- CREG 0.03
- ENSC -0.01
- Stochastic Oscillator
- CREG 17.36
- ENSC 47.62
About CREG Smart Powerr Corp.
Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.